Further studies conducted in a mouse model of non-alcoholic steatohepatitis, indicated that linagliptin improves insulin sensitivity and hepatic steatosis in mice with diet-induced obesity [168] and may ameliorate liver inflammation [169]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.